nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—malignant glioma	0.439	0.65	CbGaD
Acetylsalicylic acid—PTGS1—malignant glioma	0.15	0.222	CbGaD
Acetylsalicylic acid—PTGS2—malignant glioma	0.0858	0.127	CbGaD
Acetylsalicylic acid—TP53—skull—malignant glioma	0.00869	0.0934	CbGeAlD
Acetylsalicylic acid—HSPA5—pineal body—malignant glioma	0.00607	0.0652	CbGeAlD
Acetylsalicylic acid—TP53—endothelium—malignant glioma	0.0039	0.0419	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—malignant glioma	0.00383	0.0412	CbGeAlD
Acetylsalicylic acid—TP53—blood vessel—malignant glioma	0.00359	0.0386	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood vessel—malignant glioma	0.00354	0.038	CbGeAlD
Acetylsalicylic acid—Clotting—Temozolomide—malignant glioma	0.00221	0.0839	CcSEcCtD
Acetylsalicylic acid—TP53—embryo—malignant glioma	0.00214	0.023	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—malignant glioma	0.00211	0.0227	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—malignant glioma	0.00207	0.0222	CbGeAlD
Acetylsalicylic acid—TP53—brainstem—malignant glioma	0.00196	0.0211	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—malignant glioma	0.00193	0.0208	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—malignant glioma	0.00189	0.0204	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—malignant glioma	0.00186	0.02	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—malignant glioma	0.00183	0.0196	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—malignant glioma	0.00176	0.0189	CbGeAlD
Acetylsalicylic acid—TP53—telencephalon—malignant glioma	0.00174	0.0187	CbGeAlD
Acetylsalicylic acid—NFKBIA—telencephalon—malignant glioma	0.00172	0.0184	CbGeAlD
Acetylsalicylic acid—HSPA5—telencephalon—malignant glioma	0.00168	0.0181	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—malignant glioma	0.00156	0.0167	CbGeAlD
Acetylsalicylic acid—RPS6KA3—telencephalon—malignant glioma	0.00143	0.0154	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—malignant glioma	0.00135	0.0145	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—malignant glioma	0.00132	0.0142	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—malignant glioma	0.0013	0.014	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—malignant glioma	0.00123	0.0132	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—malignant glioma	0.00122	0.0131	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—malignant glioma	0.00121	0.013	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—malignant glioma	0.0012	0.0129	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—malignant glioma	0.00118	0.0127	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—malignant glioma	0.00112	0.0121	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Carmustine—malignant glioma	0.00106	0.0401	CcSEcCtD
Acetylsalicylic acid—IKBKB—telencephalon—malignant glioma	0.00106	0.0114	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—malignant glioma	0.00103	0.011	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Temozolomide—malignant glioma	0.00102	0.0388	CcSEcCtD
Acetylsalicylic acid—Coagulopathy—Temozolomide—malignant glioma	0.00102	0.0385	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—spinal cord—malignant glioma	0.001	0.0108	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—malignant glioma	0.000991	0.0107	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—malignant glioma	0.000975	0.0105	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—malignant glioma	0.000969	0.0104	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—malignant glioma	0.000955	0.0103	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—malignant glioma	0.000953	0.0102	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—malignant glioma	0.000933	0.01	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS1—malignant glioma	0.00093	0.215	CrCbGaD
Acetylsalicylic acid—EDNRA—medulla oblongata—malignant glioma	0.000914	0.00983	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—malignant glioma	0.000835	0.00898	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Temozolomide—malignant glioma	0.000831	0.0315	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—central nervous system—malignant glioma	0.000813	0.00874	CbGeAlD
Acetylsalicylic acid—Respiratory failure—Temozolomide—malignant glioma	0.000805	0.0305	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—cerebellum—malignant glioma	0.000795	0.00855	CbGeAlD
Acetylsalicylic acid—TP53—brain—malignant glioma	0.000787	0.00846	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—malignant glioma	0.000785	0.00844	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—malignant glioma	0.000774	0.00832	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—malignant glioma	0.000758	0.00815	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—malignant glioma	0.000751	0.00807	CbGeAlD
Acetylsalicylic acid—Coma—Carmustine—malignant glioma	0.000748	0.0283	CcSEcCtD
Acetylsalicylic acid—PTGS1—blood vessel—malignant glioma	0.000724	0.00779	CbGeAlD
Acetylsalicylic acid—PTGS2—blood vessel—malignant glioma	0.000692	0.00744	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Carmustine—malignant glioma	0.000683	0.0259	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—brain—malignant glioma	0.000646	0.00694	CbGeAlD
Acetylsalicylic acid—Vascular purpura—Temozolomide—malignant glioma	0.000642	0.0243	CcSEcCtD
Acetylsalicylic acid—Deafness—Temozolomide—malignant glioma	0.000642	0.0243	CcSEcCtD
Acetylsalicylic acid—Thirst—Temozolomide—malignant glioma	0.000603	0.0228	CcSEcCtD
Acetylsalicylic acid—IKBKB—central nervous system—malignant glioma	0.0006	0.00645	CbGeAlD
Acetylsalicylic acid—Purpura—Temozolomide—malignant glioma	0.000596	0.0226	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000594	0.0225	CcSEcCtD
Acetylsalicylic acid—IKBKB—cerebellum—malignant glioma	0.000587	0.00631	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS1—malignant glioma	0.000542	0.125	CrCbGaD
Acetylsalicylic acid—Hypokalaemia—Carmustine—malignant glioma	0.000541	0.0205	CcSEcCtD
Acetylsalicylic acid—Meclofenamic acid—PTGS1—malignant glioma	0.000534	0.123	CrCbGaD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—malignant glioma	0.000531	0.123	CrCbGaD
Acetylsalicylic acid—EDNRA—brain—malignant glioma	0.000525	0.00564	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Temozolomide—malignant glioma	0.000522	0.0198	CcSEcCtD
Acetylsalicylic acid—IKBKB—brain—malignant glioma	0.000477	0.00512	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—malignant glioma	0.000462	0.00497	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—malignant glioma	0.000446	0.0048	CbGeAlD
Acetylsalicylic acid—ABCB1—blood vessel—malignant glioma	0.000428	0.0046	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS1—malignant glioma	0.000415	0.0959	CrCbGaD
Acetylsalicylic acid—Haemoglobin—Carmustine—malignant glioma	0.000413	0.0156	CcSEcCtD
Acetylsalicylic acid—PTGS2—embryo—malignant glioma	0.000413	0.00444	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Carmustine—malignant glioma	0.000411	0.0156	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Temozolomide—malignant glioma	0.000399	0.0151	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Temozolomide—malignant glioma	0.000397	0.015	CcSEcCtD
Acetylsalicylic acid—Flushing—Carmustine—malignant glioma	0.000381	0.0144	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Temozolomide—malignant glioma	0.00037	0.014	CcSEcCtD
Acetylsalicylic acid—Flushing—Temozolomide—malignant glioma	0.000369	0.014	CcSEcCtD
Acetylsalicylic acid—PTGS1—telencephalon—malignant glioma	0.000351	0.00378	CbGeAlD
Acetylsalicylic acid—PTGS2—telencephalon—malignant glioma	0.000336	0.00361	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS1—malignant glioma	0.000333	0.077	CrCbGaD
Acetylsalicylic acid—Anaemia—Carmustine—malignant glioma	0.000331	0.0125	CcSEcCtD
Acetylsalicylic acid—Agitation—Carmustine—malignant glioma	0.000329	0.0125	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Carmustine—malignant glioma	0.00032	0.0121	CcSEcCtD
Acetylsalicylic acid—Anaemia—Temozolomide—malignant glioma	0.00032	0.0121	CcSEcCtD
Acetylsalicylic acid—Agitation—Temozolomide—malignant glioma	0.000318	0.012	CcSEcCtD
Acetylsalicylic acid—Angioedema—Temozolomide—malignant glioma	0.000316	0.012	CcSEcCtD
Acetylsalicylic acid—Vertigo—Temozolomide—malignant glioma	0.000311	0.0118	CcSEcCtD
Acetylsalicylic acid—Convulsion—Carmustine—malignant glioma	0.00031	0.0117	CcSEcCtD
Acetylsalicylic acid—Salsalate—PTGS2—malignant glioma	0.00031	0.0716	CrCbGaD
Acetylsalicylic acid—Leukopenia—Temozolomide—malignant glioma	0.000309	0.0117	CcSEcCtD
Acetylsalicylic acid—Hypertension—Carmustine—malignant glioma	0.000309	0.0117	CcSEcCtD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—malignant glioma	0.000305	0.0705	CrCbGaD
Acetylsalicylic acid—Chest pain—Carmustine—malignant glioma	0.000305	0.0115	CcSEcCtD
Acetylsalicylic acid—Convulsion—Temozolomide—malignant glioma	0.0003	0.0113	CcSEcCtD
Acetylsalicylic acid—Hypertension—Temozolomide—malignant glioma	0.000298	0.0113	CcSEcCtD
Acetylsalicylic acid—Confusional state—Carmustine—malignant glioma	0.000294	0.0112	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Temozolomide—malignant glioma	0.000294	0.0111	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Carmustine—malignant glioma	0.000286	0.0108	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Carmustine—malignant glioma	0.000285	0.0108	CcSEcCtD
Acetylsalicylic acid—Confusional state—Temozolomide—malignant glioma	0.000285	0.0108	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Temozolomide—malignant glioma	0.000282	0.0107	CcSEcCtD
Acetylsalicylic acid—ALB—brain—malignant glioma	0.000278	0.00299	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Temozolomide—malignant glioma	0.000276	0.0105	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Temozolomide—malignant glioma	0.000273	0.0103	CcSEcCtD
Acetylsalicylic acid—PTGS2—medulla oblongata—malignant glioma	0.000264	0.00284	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Carmustine—malignant glioma	0.00026	0.00986	CcSEcCtD
Acetylsalicylic acid—Somnolence—Carmustine—malignant glioma	0.00026	0.00983	CcSEcCtD
Acetylsalicylic acid—ABCB1—embryo—malignant glioma	0.000255	0.00275	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Temozolomide—malignant glioma	0.000252	0.00953	CcSEcCtD
Acetylsalicylic acid—Somnolence—Temozolomide—malignant glioma	0.000251	0.0095	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Temozolomide—malignant glioma	0.000248	0.00941	CcSEcCtD
Acetylsalicylic acid—PTGS1—spinal cord—malignant glioma	0.000246	0.00265	CbGeAlD
Acetylsalicylic acid—PTGS2—midbrain—malignant glioma	0.000241	0.00259	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Carmustine—malignant glioma	0.000241	0.00911	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—malignant glioma	0.000237	0.0548	CrCbGaD
Acetylsalicylic acid—PTGS2—spinal cord—malignant glioma	0.000235	0.00253	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Temozolomide—malignant glioma	0.000233	0.00881	CcSEcCtD
Acetylsalicylic acid—ABCB1—retina—malignant glioma	0.000226	0.00243	CbGeAlD
Acetylsalicylic acid—Urticaria—Temozolomide—malignant glioma	0.000224	0.00849	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Carmustine—malignant glioma	0.000215	0.00815	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Temozolomide—malignant glioma	0.000208	0.00787	CcSEcCtD
Acetylsalicylic acid—ABCB1—telencephalon—malignant glioma	0.000208	0.00223	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Carmustine—malignant glioma	0.0002	0.00757	CcSEcCtD
Acetylsalicylic acid—PTGS1—central nervous system—malignant glioma	0.0002	0.00215	CbGeAlD
Acetylsalicylic acid—Pruritus—Temozolomide—malignant glioma	0.0002	0.00756	CcSEcCtD
Acetylsalicylic acid—CYP2C8—brain—malignant glioma	0.000196	0.0021	CbGeAlD
Acetylsalicylic acid—Dizziness—Carmustine—malignant glioma	0.000193	0.00731	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Temozolomide—malignant glioma	0.000193	0.00731	CcSEcCtD
Acetylsalicylic acid—PTGS2—central nervous system—malignant glioma	0.000191	0.00205	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—malignant glioma	0.00019	0.044	CrCbGaD
Acetylsalicylic acid—Dizziness—Temozolomide—malignant glioma	0.000187	0.00707	CcSEcCtD
Acetylsalicylic acid—PTGS2—cerebellum—malignant glioma	0.000187	0.00201	CbGeAlD
Acetylsalicylic acid—Vomiting—Carmustine—malignant glioma	0.000186	0.00703	CcSEcCtD
Acetylsalicylic acid—Rash—Carmustine—malignant glioma	0.000184	0.00697	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Carmustine—malignant glioma	0.000184	0.00697	CcSEcCtD
Acetylsalicylic acid—Vomiting—Temozolomide—malignant glioma	0.000179	0.00679	CcSEcCtD
Acetylsalicylic acid—Rash—Temozolomide—malignant glioma	0.000178	0.00674	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Temozolomide—malignant glioma	0.000178	0.00673	CcSEcCtD
Acetylsalicylic acid—Nausea—Carmustine—malignant glioma	0.000173	0.00657	CcSEcCtD
Acetylsalicylic acid—Nausea—Temozolomide—malignant glioma	0.000168	0.00635	CcSEcCtD
Acetylsalicylic acid—ABCB1—medulla oblongata—malignant glioma	0.000163	0.00175	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—malignant glioma	0.000159	0.0017	CbGeAlD
Acetylsalicylic acid—PTGS2—brain—malignant glioma	0.000152	0.00163	CbGeAlD
Acetylsalicylic acid—ABCB1—midbrain—malignant glioma	0.000149	0.0016	CbGeAlD
Acetylsalicylic acid—ABCB1—spinal cord—malignant glioma	0.000146	0.00156	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—malignant glioma	0.000118	0.00127	CbGeAlD
Acetylsalicylic acid—ABCB1—cerebellum—malignant glioma	0.000115	0.00124	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—malignant glioma	9.37e-05	0.00101	CbGeAlD
Acetylsalicylic acid—PTGS2—Disease—HES1—malignant glioma	4.81e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS1—malignant glioma	4.79e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NCOR1—malignant glioma	4.78e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.77e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS1—malignant glioma	4.76e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SPP1—malignant glioma	4.76e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.74e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PIK3CA—malignant glioma	4.72e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—malignant glioma	4.71e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BCL2—malignant glioma	4.7e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.68e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—malignant glioma	4.66e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—RAF1—malignant glioma	4.65e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—malignant glioma	4.65e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MDM2—malignant glioma	4.63e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RAF1—malignant glioma	4.62e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—malignant glioma	4.6e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PDGFRA—malignant glioma	4.58e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—malignant glioma	4.57e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—malignant glioma	4.57e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—malignant glioma	4.57e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTT1—malignant glioma	4.56e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—malignant glioma	4.55e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CB—malignant glioma	4.54e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PIK3CA—malignant glioma	4.53e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—malignant glioma	4.53e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—malignant glioma	4.53e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—malignant glioma	4.51e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—malignant glioma	4.51e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CB—malignant glioma	4.51e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTT1—malignant glioma	4.45e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BCHE—malignant glioma	4.45e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BCHE—malignant glioma	4.43e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.42e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.42e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PDGFB—malignant glioma	4.41e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.4e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.39e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGFR1—malignant glioma	4.38e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC5A5—malignant glioma	4.37e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—malignant glioma	4.35e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—malignant glioma	4.35e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.32e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HIF1A—malignant glioma	4.32e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—malignant glioma	4.3e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS1—malignant glioma	4.28e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.26e-06	2.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.26e-06	2.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAT—malignant glioma	4.24e-06	2.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—malignant glioma	4.21e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HLA-A—malignant glioma	4.21e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—malignant glioma	4.21e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—malignant glioma	4.21e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CAV1—malignant glioma	4.18e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS1—malignant glioma	4.17e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—malignant glioma	4.17e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTT1—malignant glioma	4.16e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.16e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—malignant glioma	4.16e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—malignant glioma	4.14e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.14e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KDR—malignant glioma	4.13e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.12e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—malignant glioma	4.12e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—malignant glioma	4.12e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PDGFB—malignant glioma	4.11e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CAV1—malignant glioma	4.11e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.1e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR1—malignant glioma	4.09e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—malignant glioma	4.08e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.03e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HIF1A—malignant glioma	4.03e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NCOR1—malignant glioma	4e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CA—malignant glioma	4e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BCHE—malignant glioma	3.97e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—F2—malignant glioma	3.97e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FN1—malignant glioma	3.97e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—malignant glioma	3.95e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BAD—malignant glioma	3.93e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.93e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.93e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS1—malignant glioma	3.9e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CAV1—malignant glioma	3.89e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—malignant glioma	3.89e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH1—malignant glioma	3.89e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—malignant glioma	3.89e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—malignant glioma	3.89e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.88e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BCHE—malignant glioma	3.88e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—malignant glioma	3.87e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—malignant glioma	3.85e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC5A5—malignant glioma	3.83e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD80—malignant glioma	3.81e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APC—malignant glioma	3.8e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CG—malignant glioma	3.8e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGF—malignant glioma	3.76e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CG—malignant glioma	3.74e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTPN11—malignant glioma	3.74e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.71e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—malignant glioma	3.7e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.68e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BAD—malignant glioma	3.66e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOTCH1—malignant glioma	3.63e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BCHE—malignant glioma	3.62e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—malignant glioma	3.61e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.59e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.58e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—malignant glioma	3.57e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.57e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—malignant glioma	3.57e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—malignant glioma	3.57e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD80—malignant glioma	3.55e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—malignant glioma	3.55e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—malignant glioma	3.55e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—malignant glioma	3.54e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.53e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—malignant glioma	3.52e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGF—malignant glioma	3.51e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTPN11—malignant glioma	3.49e-06	1.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—malignant glioma	3.48e-06	1.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT2—malignant glioma	3.48e-06	1.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—malignant glioma	3.46e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—malignant glioma	3.46e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—malignant glioma	3.45e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—malignant glioma	3.43e-06	1.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.39e-06	1.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.35e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—malignant glioma	3.34e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—malignant glioma	3.33e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—malignant glioma	3.29e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—malignant glioma	3.26e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAV1—malignant glioma	3.26e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NCOR1—malignant glioma	3.26e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT2—malignant glioma	3.25e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NCOR1—malignant glioma	3.24e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—malignant glioma	3.23e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.21e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF2—malignant glioma	3.2e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—malignant glioma	3.17e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—malignant glioma	3.16e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—malignant glioma	3.12e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.12e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—malignant glioma	3.09e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—malignant glioma	3.08e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—malignant glioma	3.01e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—malignant glioma	3e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—malignant glioma	3e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—malignant glioma	2.99e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF2—malignant glioma	2.99e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RAF1—malignant glioma	2.98e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—malignant glioma	2.97e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—malignant glioma	2.95e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.93e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—malignant glioma	2.92e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—malignant glioma	2.92e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—malignant glioma	2.91e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOR1—malignant glioma	2.91e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—malignant glioma	2.88e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—malignant glioma	2.87e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—malignant glioma	2.87e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—malignant glioma	2.84e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOR1—malignant glioma	2.84e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—malignant glioma	2.81e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—malignant glioma	2.8e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—malignant glioma	2.79e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RAF1—malignant glioma	2.78e-06	1.38e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—malignant glioma	2.77e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—malignant glioma	2.75e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—malignant glioma	2.75e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—malignant glioma	2.72e-06	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—malignant glioma	2.68e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—malignant glioma	2.68e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—malignant glioma	2.68e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAV1—malignant glioma	2.65e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOR1—malignant glioma	2.65e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAV1—malignant glioma	2.64e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—malignant glioma	2.61e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.54e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—malignant glioma	2.53e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.52e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—malignant glioma	2.52e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—malignant glioma	2.48e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.42e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—malignant glioma	2.4e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAV1—malignant glioma	2.37e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—malignant glioma	2.35e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—malignant glioma	2.33e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—malignant glioma	2.32e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAV1—malignant glioma	2.31e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—malignant glioma	2.28e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—malignant glioma	2.27e-06	1.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.26e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—malignant glioma	2.26e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—malignant glioma	2.25e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—malignant glioma	2.24e-06	1.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAV1—malignant glioma	2.16e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.16e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.13e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—malignant glioma	2.11e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—malignant glioma	2.11e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—malignant glioma	2.1e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—malignant glioma	2.09e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—malignant glioma	2.08e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.06e-06	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—malignant glioma	2.05e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—malignant glioma	2.03e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.97e-06	9.75e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—malignant glioma	1.97e-06	9.75e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—malignant glioma	1.95e-06	9.68e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—malignant glioma	1.93e-06	9.58e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—malignant glioma	1.91e-06	9.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—malignant glioma	1.9e-06	9.41e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.9e-06	9.4e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.85e-06	9.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—malignant glioma	1.85e-06	9.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—malignant glioma	1.84e-06	9.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—malignant glioma	1.84e-06	9.1e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—malignant glioma	1.83e-06	9.05e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—malignant glioma	1.8e-06	8.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—malignant glioma	1.78e-06	8.81e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—malignant glioma	1.75e-06	8.67e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.73e-06	8.57e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—malignant glioma	1.72e-06	8.52e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—malignant glioma	1.66e-06	8.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.65e-06	8.2e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—malignant glioma	1.64e-06	8.12e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—malignant glioma	1.61e-06	8e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—malignant glioma	1.6e-06	7.93e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—malignant glioma	1.6e-06	7.93e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—malignant glioma	1.59e-06	7.89e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.51e-06	7.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—malignant glioma	1.49e-06	7.41e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—malignant glioma	1.45e-06	7.19e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—malignant glioma	1.43e-06	7.08e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—malignant glioma	1.43e-06	7.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—malignant glioma	1.39e-06	6.91e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—malignant glioma	1.39e-06	6.88e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—malignant glioma	1.35e-06	6.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—malignant glioma	1.3e-06	6.46e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—malignant glioma	1.13e-06	5.62e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.13e-06	5.6e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—malignant glioma	1.12e-06	5.57e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.01e-06	5e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—malignant glioma	9.84e-07	4.88e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—malignant glioma	9.23e-07	4.57e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—malignant glioma	9.19e-07	4.56e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—malignant glioma	9.17e-07	4.55e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—malignant glioma	8.23e-07	4.08e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—malignant glioma	8.04e-07	3.98e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—malignant glioma	7.51e-07	3.72e-06	CbGpPWpGaD
